Travel Grants - Alpha-1 Foundation
Alpha-1 Foundation’s Travel Grants support investigators’ travel to present AAT-related research or receive laboratory cross-training, advancing a research mission to improve health and find a cure.
Funder: Alpha-1 Foundation
Due Dates: At least 2 months before travel (Travel Grant LOI) | September 25, 2026 (Shared in-cycle LOI) | February 12, 2027 (Shared in-cycle application)
Funding Amounts: Up to $1,000 for conference presentation or laboratory cross-training travel
Summary: Supports travel to present AAT-related research at scientific meetings or receive cross-training at established Alpha-1 laboratories.
Key Information: Contact Grants Administration Manager Vanessa Valencia before preparing or submitting a Travel Grant LOI.
Description
The Alpha-1 Foundation’s Travel Grants support two activities: presenting alpha-1 antitrypsin (AAT)-related abstracts or posters at national or international scientific conferences, and receiving cross-training at an established Alpha-1 laboratory under an established Alpha-1 investigator. Training may cover diagnostic and therapeutic procedures, research techniques, or specialized equipment and software applicable to AAT-related research.
Travel Grants are listed within the Foundation’s 2026–2027 In-Cycle Grants Award Program. The broader program aims to improve the health of people with AAT deficiency and ultimately find a cure, supporting research into Alpha-1-related lung and liver disease, treatments and care, and ethical, legal, and social issues. Travel support is specifically directed toward scientific presentation and laboratory cross-training within that research mission.
